Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation
Clinical Trials - The Bloodline with LLS
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies. We also discuss the critical role of clinical trials in shaping the future of CTCL care.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Cutaneous T-cell Lymphoma Fact Sheet
- Recent LLS T-cell lymphoma webcast
- LLS Clinical Trial Support Center
- ClinicalTrials.gov
- Stem cell transplantation
- CAR T-cell therapy
- Bispecific antibodies – Immunotherapy fact sheet
Additional LLS Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Online chats
- Support groups
- Caregiver support
- Caregiver Workbook
- Advocacy and Public Policy
- Survivorship Workbook
- LLS Community
- Mental Health Resources
Supported by Kyowa Kirin, Inc.
The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.